![Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World](https://static-02.hindawi.com/articles/bmri/volume-2014/528105/figures/528105.fig.001e.jpg)
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
![Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/44/4/519/F5.large.jpg?width=800&height=600&carousel=1)
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
![Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study - ACR Meeting Abstracts Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2021/09/ACR_1065475_1.jpg)
Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study - ACR Meeting Abstracts
![Frontiers | Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study Frontiers | Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study](https://www.frontiersin.org/files/Articles/490227/fphar-10-01497-HTML-r1/image_m/fphar-10-01497-t001.jpg)
Frontiers | Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
![Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-018-1739-0/MediaObjects/13075_2018_1739_Fig1_HTML.png)
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text
![JCM | Free Full-Text | DNA Fragmentation in Viable and Non-Viable Spermatozoa Discriminates Fertile and Subfertile Subjects with Similar Accuracy | HTML JCM | Free Full-Text | DNA Fragmentation in Viable and Non-Viable Spermatozoa Discriminates Fertile and Subfertile Subjects with Similar Accuracy | HTML](https://www.mdpi.com/jcm/jcm-09-01341/article_deploy/html/images/jcm-09-01341-g001-550.jpg)
JCM | Free Full-Text | DNA Fragmentation in Viable and Non-Viable Spermatozoa Discriminates Fertile and Subfertile Subjects with Similar Accuracy | HTML
![Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-018-1739-0/MediaObjects/13075_2018_1739_Fig3_HTML.png)
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text
![Frontiers | Harnessing Big Data, Smart and Digital Technologies and Artificial Intelligence for Preventing, Early Intercepting, Managing, and Treating Psoriatic Arthritis: Insights From a Systematic Review of the Literature Frontiers | Harnessing Big Data, Smart and Digital Technologies and Artificial Intelligence for Preventing, Early Intercepting, Managing, and Treating Psoriatic Arthritis: Insights From a Systematic Review of the Literature](https://www.frontiersin.org/files/Articles/847312/fimmu-13-847312-HTML/image_m/fimmu-13-847312-g001.jpg)
Frontiers | Harnessing Big Data, Smart and Digital Technologies and Artificial Intelligence for Preventing, Early Intercepting, Managing, and Treating Psoriatic Arthritis: Insights From a Systematic Review of the Literature
![Psoriatic Arthritis Remission Compared With Very Low Disease Activity, DAPSA Criteria - Rheumatology Advisor Psoriatic Arthritis Remission Compared With Very Low Disease Activity, DAPSA Criteria - Rheumatology Advisor](https://www.rheumatologyadvisor.com/wp-content/uploads/sites/18/2019/02/PsA_MI_01B23BGZ-860x573.jpg)
Psoriatic Arthritis Remission Compared With Very Low Disease Activity, DAPSA Criteria - Rheumatology Advisor
![POS1069 VALIDATION OF THE DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS ( DAPSA) WITH A QUICK QUANTITATIVE C-REACTIVE PROTEIN ASSAY (Q-DAPSA) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA): A PROSPECTIVE, NATIONAL, MULTICENTER STUDY | Annals POS1069 VALIDATION OF THE DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS ( DAPSA) WITH A QUICK QUANTITATIVE C-REACTIVE PROTEIN ASSAY (Q-DAPSA) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA): A PROSPECTIVE, NATIONAL, MULTICENTER STUDY | Annals](https://ard.bmj.com/content/annrheumdis/80/Suppl_1/813/F1.large.jpg)
POS1069 VALIDATION OF THE DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS ( DAPSA) WITH A QUICK QUANTITATIVE C-REACTIVE PROTEIN ASSAY (Q-DAPSA) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA): A PROSPECTIVE, NATIONAL, MULTICENTER STUDY | Annals
![Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis Using Data From an Interventional Study With Golimumab - Helliwell - 2014 - Arthritis Care & Research - Wiley Online Library Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis Using Data From an Interventional Study With Golimumab - Helliwell - 2014 - Arthritis Care & Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4c41f0ce-0df1-483f-8176-914b72ea3dab/acr22204-math-0001.gif)
Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis Using Data From an Interventional Study With Golimumab - Helliwell - 2014 - Arthritis Care & Research - Wiley Online Library
![Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World](https://static-02.hindawi.com/articles/bmri/volume-2014/528105/figures/528105.fig.002a.jpg)
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
![PDF) Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World | Fausto Salaffi - Academia.edu PDF) Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World | Fausto Salaffi - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/45640401/mini_magick20190211-24698-nbjy3k.png?1549927143)
PDF) Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World | Fausto Salaffi - Academia.edu
![Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score | Annals of the Rheumatic Diseases Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/75/5/811/F1.large.jpg?width=800&height=600&carousel=1)
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score | Annals of the Rheumatic Diseases
![Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial - The Lancet Rheumatology Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial - The Lancet Rheumatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bc1cb516-3519-404b-b79e-531f6d3aef12/gr2_lrg.jpg)